OAB0203 Optimal timing for ART initiation in ART-naive children and adolescents living with HIV following the diagnosis of HIV-associated TBOral abstract session with live Q&ATB/HIV co-infection in paediatric and adolescent populations (including treatment and prevention)
OAB0204 Subcortical brain volumes of children who are HIV-exposed and uninfected in the first three years of life: a South African birth cohort studyOral abstract session with live Q&AHIV-exposed uninfected children
OAB0205 Probability of AIDS and non-AIDS-related mortality of early-treated children living with HIV-1Oral abstract session with live Q&AARV management strategies in paediatric and adolescent populations
OAB0302 Efficacy and safety of dolutegravir plusemtricitabinevs combined antiretroviral therapy for the maintenance of viral suppression: 144-week results of the SIMPL'HIV trialOral abstract session with live Q&AART in acute, first- and second-line therapies
OAB0303 Dual therapy based on DRVr plus 3TC in HIV-1 naïve patients: global 48 week results from ANDES StudyOral abstract session with live Q&AART in acute, first- and second-line therapies
OAB0304 Dolutegravir versus efavirenz-400 as first-line ART in Cameroon: week 192 data of NAMSAL trialOral abstract session with live Q&AART in acute, first- and second-line therapies
OAB0305 Survival in advanced AIDS patients treated with efavirenz or dolutegravir in Brazil: a multicenter, observational studyOral abstract session with live Q&AART in acute, first- and second-line therapies
OAB0402 Efficacy and safety results in participants co-infected with HIV from TB-PRACTECAL Clinical TrialOral abstract session with live Q&ATuberculosis: Prevention, diagnosis, treatment
OAB0403 Impact of a community-wide HIV test and treat intervention on population-level tuberculosis transmission in rural UgandaOral abstract session with live Q&ATuberculosis: Prevention, diagnosis, treatment
OAB0404 Are people living with HIV at higher risk of severe and fatal COVID-19?Oral abstract session with live Q&AClinical manifestations and features of COVID-19 and HIV co-infection
21 - 30 of 2486 items